Late hematological effects in the atomic bomb survivors

International Congress Series

Volumn 1299, Issue , 2007, Pages 67-72

  Tsukasaki, Kunihiro ^a   Iwanaga, Masako ^a   Tomonaga, Masao ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

Atomic bomb survivors; Epidemiology; Monoclonal gammopathy of undetermined significance; Myelodysplastic sundrome; Radiation exposure

Indexed keywords

EID: 33847648505     PISSN: 05315131     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.ics.2006.10.002     Document Type: Article

References (12)

1. Tomonaga M., Matsuo T., Carter R.L., et al. Differential Effects of Atomic Bomb Irradiation in Inducing Major Leukemia Types: Analyses of Open-City Cases Including the Life Span Study Cohort Based upon Updated Diagnostic Systems and the Dosimetry System (DS86). Technical Report vol. 9-91 (1986) RERF
2. Preston D.L., Kusumi S., Tomonaga M., et al. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987. Radiat. Res. 137 (1994) S68-S97
3. Bennett J.M., Catovsky D., Daniel M.T., et al. Proposals for the classification of the myelodysplastic syndromes. Br. J. Haematol. 51 (1982) 189-199
4. Kyle R.A., Therneau T.M., Rajkumar S.V., et al. Long-term study of prognosis of monoclonal gammopathy of undetermined significance. N. Engl. J. Med. 346 (2002) 564-569
5. Oda K., Kimura A., Matsuo T., Tomonaga M., Kodama K., and Mabuchi K. Increased relative risk of myelodysplastic syndrome in atomic bomb survivors. Nagasaki Med. J. 73 (1998) 174-179 (Suppl., in Japanese)
6. Kimura A., Takeuchi Y., Tanaka H., Satoh K., Ohtaki M., and Hayakawa N. Atomic bomb radiation enhances the risk of MDS. Leuk. Res. 25 (2001) S13 (Suppl.)
7. Neriishi K., Nakashima E., and Suzuki G. Monoclonal gammopathy of undetermined significance in atomic bomb survivors: incidence and transformation to multiple myeloma. Br. J. Haematol. 121 (2003) 405-410
8. Gilbert E.S., Petersen G.R., and Buchanan J.A. Mortality of workers at the Hanford site: 1945-1981. Health Phys. 56 (1989) 11-25
9. Gluzman D., Imamura N., Sklyarenko L., Nadgornaya V., Zavelevich M., and Machilo V. Malignant diseases of hematopoietic and lymphoid tissues in Chernobyl clean-up workers. Hematol. J. 5 (2005) 565-571
10. Amenomori T., Honda T., Otake M., Tomonaga M., and Ichimaru M. Growth and differentiation of circulating hemopoietic stem cells with atomic bomb irradiation-induced chromosome abnormalities. Exp. Hematol. 16 (1988) 849-854
11. Kusunoki Y., Kodama Y., Hirai Y., Kyoizumi S., Nakamura N., and Akiyama M. Cytogenetic and immunologic identification of clonal expansion of stem cells into T and B lymphocytes in one Atomic-bomb survivor. Blood 86 (1995) 2106-2112
12. Preston D.L., Shimizu Y., Pierce D.A., Suyama A., and Mabuchi K. Studies of mortality of atomic bomb survivors. Report 13: solid cancer and noncancer disease mortality: 1950-1997. Radiat. Res. 160 (2003) 381-407